Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/02/2001US6297355 Preferential hepatitis viral protein; for the prevention, treament and detection of viral infection
10/02/2001US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups
10/02/2001US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter
10/02/2001US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed.
10/02/2001US6297215 Microbiocides for treatment of endotoxemia or sepsis by administering
10/02/2001US6297213 Osteogenic devices
10/02/2001US6297212 Regeneration of involuted thymus and injection into target for treatment of autoimmune diseases
10/02/2001US6297054 Editing-based selectable plastid marker genes
10/02/2001US6297053 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/02/2001US6297052 Cell culture; for use in proliferation of preferential compounds in cells
10/02/2001US6297050 Activation of t-cell response; mix peptides with sample containing t-cells and detect bound human leukocyte antigens
10/02/2001US6297048 Expression vector for use in treatment of viral infections and caner
10/02/2001US6297041 MN gene and protein
10/02/2001US6297030 Human Wnt-7a polynucleotides
10/02/2001US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor
10/02/2001US6297027 Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
10/02/2001US6297026 Nucleic acids encoding the C140 receptor
10/02/2001US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
10/02/2001US6297019 Recombinant polynucleotides encoding CYP7 promoter-binding factors
10/02/2001US6297012 Cytoplasmic male sterility DNA factor and utilization thereof
10/02/2001US6297011 Mammalian tolloid-like gene and protein
10/02/2001US6297003 Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region
10/02/2001US6296855 17-KDA Brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
10/02/2001US6296854 Live attenuated Venezuelan Equire encephalitis vaccine
10/02/2001US6296853 For therapy of animal having a papilloma viral infection
10/02/2001US6296852 For protecting poultry from disease; used to generate immune response in commercial poultry
10/02/2001US6296851 For screening antibiotics
10/02/2001US6296850 Apoptosis-related compounds and their use
10/02/2001US6296849 Methods and compositions including a 13kDa B. burgdorferi protein
10/02/2001US6296848 GRB2 associating polypeptides and nucleic acids encoding therefor
10/02/2001US6296844 Administering asialointerferon-.beta.. to mammal for therapy of viral hepatitis
10/02/2001US6296843 Mutagenized IL 13-based chimeric molecules
10/02/2001US6296807 Kits for the detection of human immunodeficiency virus type 2 (HIV-2) antigens
10/02/2001CA2151142C Glycoprotein ligand for p-selectin and methods of use thereof
10/02/2001CA2148223C Bacteriocins from streptococcus thermophilus
10/02/2001CA2086243C Anticoagulant peptides
10/02/2001CA2078000C Neutrophil stimulating peptides
10/02/2001CA2035917C Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
10/02/2001CA2020668C Fused or hybrid protein comprising viral antigen and lymphokine
10/02/2001CA2001720C Membrane affinity apparatus and purification methods related thereto
10/02/2001CA1341299C Mammalian interleukin-4
09/2001
09/30/2001CA2341971A1 Method for quantifying dna binding activity of dna binding proteins
09/30/2001CA2340461A1 Hirulog-like peptide and gene therapy
09/27/2001WO2001071359A2 Methods for identifying and isolating tissue-specific lumen-exposed molecules
09/27/2001WO2001071358A1 Method of screening for inhibitors of osteopontin
09/27/2001WO2001071356A2 Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof
09/27/2001WO2001071346A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them
09/27/2001WO2001071309A2 Methods and reagents for regulation of cellular responses in biological systems
09/27/2001WO2001071046A1 Suppressor of hiv replication and transcription
09/27/2001WO2001071038A1 Inhibition of penicillin resistance in s. pneumoniae
09/27/2001WO2001071032A1 Method of detecting risk factor for the onset of arteriosclerosis
09/27/2001WO2001071029A1 Diagnosis of a person's risk of developing alcoholism
09/27/2001WO2001071017A2 Modified nodavirus rna for gene delivery
09/27/2001WO2001071013A2 Melon promoters for expression of transgenes in plants
09/27/2001WO2001071006A2 Method for isolating in vitro differentiated somatic cells
09/27/2001WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
09/27/2001WO2001071000A1 Novel polypeptide--- a znt-1-22 and polynucleotide encoding it
09/27/2001WO2001070999A1 Novel polypeptide --- the amyloid precursor protein --- binding protein and polynucleotide encoding it
09/27/2001WO2001070992A1 Proteins and polypeptides from haemophilus influenza involved in paracytosis, nucleotide sequences encoding them and uses thereof
09/27/2001WO2001070991A1 Vaccine against mycobacterium infection based on epitopes of ag85 complex
09/27/2001WO2001070990A1 Nucleic acid sequences comprising at least a phage-resistance mechanism, plasmids containing same, lactic acid bacteria and use
09/27/2001WO2001070989A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
09/27/2001WO2001070988A2 Receptors for hypersensitive response elicitors and uses thereof
09/27/2001WO2001070987A2 Novel inflorescence meristem development gene, promoter, and methods of use for same
09/27/2001WO2001070986A2 Helical protein zalpha51
09/27/2001WO2001070985A2 Bi-functional cancer treatment agents
09/27/2001WO2001070982A2 Brca-1 regulators and methods of use
09/27/2001WO2001070981A2 Nucleic acids and polypeptides of invertebrate g-protein coupled receptors and methods of use
09/27/2001WO2001070980A2 Isolated g-protein coupled receptors, nucleic acid molecules encoding gpcr proteins, and uses thereof as insecticidal targets
09/27/2001WO2001070979A2 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
09/27/2001WO2001070978A2 Polypeptides and nucleic acids encoding same
09/27/2001WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof
09/27/2001WO2001070976A2 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
09/27/2001WO2001070975A1 Novel melanin concentrating hormone receptor
09/27/2001WO2001070974A1 Novel protein, process for producing the same and use thereof
09/27/2001WO2001070973A1 Precursors of silk-like materials, silk-like materials and processes for producing both
09/27/2001WO2001070972A2 Multiple human and mouse otoferlin isoforms
09/27/2001WO2001070971A2 Regulation of human mas oncogene-related g protein-coupled receptor
09/27/2001WO2001070970A2 Regulation of human opsin-related g protein-coupled receptor
09/27/2001WO2001070969A2 Regulation of human latrophilin-like g protein-coupled receptor
09/27/2001WO2001070968A2 Production of recombinant blood clotting factors in human cell lines
09/27/2001WO2001070967A2 Regulation of human serotonin-like g protein-coupled receptor
09/27/2001WO2001070966A1 A novel polypeptide, a human clathrin light chain 11 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070965A1 A novel polypeptide, a human regulatory transcription factor 15 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070964A1 A novel polypeptide, a human glucose transport like protein 18 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070962A1 A novel polypeptide, a human plasminogen activator inhibitor 10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070961A1 A novel polypeptide, a human microtubulin folding factor c16 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070960A1 A novel polypeptide, a human dna mismatch repair gene protein 13 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070959A1 A novel polypeptide, a human regulatory transcription factor 10 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070958A1 A novel polypeptide, a human dna mismatch repair protein 15 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070957A1 A novel polypeptide, a human dna mismatch repair protein 9.4 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070956A1 A novel polypeptide, a human dna mismatch repair protein 8 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070955A2 Identification of essential genes in prokaryotes
09/27/2001WO2001070954A2 Regulation of human nerve growth factor-elated g protein-coupled receptor
09/27/2001WO2001070952A1 Human gata-5 transcription factor
09/27/2001WO2001070951A2 Agent for the diagnosis and therapy of viral diseases
09/27/2001WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
09/27/2001WO2001070944A2 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
09/27/2001WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
09/27/2001WO2001070940A1 Genetic constructs for regulated expression of insulin